Barclays’s AdaptHealth AHCO Stock Holding History
Bought
Maintained
Sold
Other funds holding AHCO
Barclays's AHCO Position: Q3 2026 in Review
Barclays increased its AdaptHealth (AHCO) stake by 1,179% in Q3 2026, buying an estimated $2.1M and bringing the position to 302,263 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2698.
Barclays first reported a position in AHCO in Q1 2022 and has held it in 19 quarters since. The position peaked at $3.59M in Q3 2022. 93 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.
- Barclays held 302,263 shares of AdaptHealth worth $1.7M as of Q3 2026.
- Barclays bought 278,621 AdaptHealth shares in Q3 2026, an estimated $2.1M.
- AdaptHealth made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2698 holding.
- Barclays first reported a position in AdaptHealth in Q1 2022 and has held it in 19 quarters since.
- Barclays's AdaptHealth position peaked at $3.59M in Q3 2022.
- 93 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.